Interleukin-5 plays an essential role in the recruitment of eosinophils to the airways, and today, anti-IL-5 and anti-immunoglobulin E (IgE) monoclonal antibodies are already used to reduce the exacerbation of asthma [9,38]. Here, IGHE is linked to asthma.